At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 538 enrolled
Drug / intervention
4 mL injection of Ampion +1 morebiological
Likely dose
4 mL injection of Ampionfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 3 Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of a Single Intra-articular Injection of Ampion in Adults With Pain Due to Osteoarthritis (OA) of the Knee
In Brief
A Phase 3 clinical trial evaluating 4 mL injection of Ampion and 4 mL Injection of Placebo for Osteoarthritis of the Knee. Completed, enrolled 538 participants.
Detailed Summary
This study will evaluate the efficacy of an Intra-Articular Injection of Ampion™ in Adults with pain due to osteoarthritis of the knee.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis of the Knee
Countries--
Collaborators--
Timeline
Phase 3CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedDec 2013
Enrollment StartJan 2014
Primary CompletionMay 2014
Study CompletionJul 2014
TodayJul 2026
First PostedDec 31, 2013
Enrollment StartJan 1, 2014
Primary CompletionMay 1, 2014
Study CompletionJul 1, 2014
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 12.5 years ago
Interventions
4 mL injection of Ampionbiological
4 mL injection of Ampion
4 mL Injection of Placebodrug
4 mL Injection of Placebo